Schelto Kruijff

Schelto Kruijff is a Dutch surgical oncologist and academic researcher, a professor of surgery affiliated with the University Medical Center Groningen (UMCG) and the University of Groningen (RUG). His work focuses on surgical oncology, the use of fluorescence-guided surgery, endocrine tumor treatment, and sustainability in healthcare.

Education

In 2011, Kruijff earned a Doctor of Philosophy (PhD) degree at the University of Groningen, where his doctoral dissertation focused on biomarkers in melanoma. Following his doctorate, he completed postdoctoral training, including a TS Reeve Endocrine Surgery Fellowship at the University of Sydney, Australia. He later undertook additional fellowship experience in hepatobiliary surgery after returning to the Netherlands. His clinical practice includes the surgical treatment of endocrine tumors, such as thyroid and adrenal gland tumors, as well the treatment of adrenal tumors. He was appointed Chief Green Officer of UMCG, a role focused on promoting sustainability and reducing the environmental impact of healthcare delivery.

Research Kruijff's research covers surgical innovation, oncological outcomes, imaging techniques, and perioperative technologies. His work includes studies on fluorescence-guided surgery and optical imaging in thyroid and parathyroid procedures, as well as translational and clinical research in cancer care.

He has contributed to academic and public discussions on sustainable innovation in surgery and healthcare systems, including lectures and media interviews addressing environmentally responsible medical practice.

Selected publications

''Studies on quantitative near-infrared fluorescence imaging using indocyanine green in surgical settings.